Europe — EMA
Nutriflex Lipid 32/64/40 Perifer
GNH USA supplies Nutriflex Lipid 32/64/40 Perifer (Valine), a parenteral lipid nutrition product for post‑operative recovery and severe malnutrition.
Request sourcing
What is Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonin?
Valine, the active ingredient in Nutriflex Lipid 32/64/40 Perifer, is a branched‑chain amino acid presented as a sterile lipid emulsion for parenteral use. It supports metabolic needs and membrane synthesis in patients requiring intravenous nutrition.
GNH USA supplies Nutriflex Lipid 32/64/40 Perifer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.
What is Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonin used for?
Nutriflex Lipid 32/64/40 Perifer provides parenteral lipid nutrition for patients with increased metabolic demand or impaired oral intake. - Post‑operative recovery: supplies essential fatty acids to support wound healing and energy needs. - Severe malnutrition: delivers calories and essential lipids when enteral feeding is not feasible. - Long‑term parenteral nutrition: maintains nutritional status in patients with chronic gastrointestinal failure.
What are the side effects of Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonin?
Nutriflex Lipid 32/64/40 Perifer may be associated with infusion‑related reactions and metabolic disturbances.
Common Side Effects: - Hypertriglyceridaemia: elevated serum triglyceride levels during therapy. - Fever or chills: transient temperature rise during infusion. - Mild hepatic enzyme elevation: slight increase in ALT/AST. - Electrolyte shifts: changes in phosphate or magnesium levels. - Local vein irritation: discomfort at the infusion site.
Serious or Rare Side Effects: - Anaphylactic reaction: acute hypersensitivity requiring immediate intervention. - Fat overload syndrome: excessive lipid accumulation leading to organ dysfunction. - Pulmonary embolism: lipid droplets entering the pulmonary circulation. - Severe hyperlipidaemia: marked rise in serum lipids with pancreatitis risk. - Coagulopathy: impaired clotting due to lipid‑induced platelet dysfunction.
What precautions apply to Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonin?
When prescribing Nutriflex Lipid 32/64/40 Perifer, clinicians should assess metabolic status and monitor laboratory parameters. - Baseline lipid profile: obtain triglyceride and cholesterol levels before initiation. - Liver function monitoring: check ALT, AST, and bilirubin regularly. - Glycaemic control: observe blood glucose in diabetic patients. - Electrolyte balance: monitor phosphate, magnesium and calcium during therapy. - Infusion rate: administer according to recommended guidelines to reduce risk of fat overload. - Store at ambient temperature: keep in original container, protect from light and moisture.
What does Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonin interact with?
Nutriflex Lipid 32/64/40 Perifer can interact with other intravenous therapies and metabolic modulators.
Major Interactions (Avoid): - Propofol: concurrent lipid infusion may cause cumulative fat load and hypertriglyceridaemia. - Heparin: may increase plasma lipase activity, enhancing triglyceride breakdown and risk of fat overload. - High‑dose vitamin A: excess fat‑soluble vitamins can accumulate in the lipid phase.
Moderate Interactions (Monitor Closely): - Insulin therapy: lipid infusion can affect glycaemic control, requiring dose adjustments. - Anticoagulants: lipid particles may alter plasma protein binding, affecting anticoagulant activity. - Other parenteral nutrition components: coordinate macronutrient ratios to avoid excess calories.